Tandem Diabetes Care
TNDM
TNDM
200 hedge funds and large institutions have $1.81B invested in Tandem Diabetes Care in 2018 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 74 increasing their positions, 57 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
200
Holders Change
+16
Holders Change %
+8.7%
% of All Funds
4.46%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
46
Increased
74
Reduced
57
Closed
30
Calls
$56.2M
Puts
$38.8M
Net Calls
+$17.4M
Net Calls Change
-$34.5M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$215M |
| 2 |
Renaissance Technologies
New York
|
$53.6M |
| 3 |
CCI
Columbus Circle Investors
|
$32.2M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
$62.3M |
| 5 |
DCM
Daruma Capital Management
New York
|
$18.9M |
Top Sellers
| 1 |
HCM
Hitchwood Capital Management
New York
|
$0 |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
$8.81M |
| 3 |
BC
Broadfin Capital
New York
|
$3.38M |
| 4 |
Two Sigma Investments
New York
|
$24.4M |
| 5 |
Goldman Sachs
New York
|
$19.6M |
